The #AI Eye: IBM ( $IBM) to Invest $50 Million in Research With Hospital and Medical Center and Qualcomm ($QCOM)

Global AI Chipset Market to Approach $13.4 Billion USD by 2023

Mind Commerce has published new research via In For Growth, indicating that the global AI chipset market will approach $13.4 billion USD by 2023, with the US generating over $3.5 billion. An excerpt from the report summary reads:

The AI chipset marketplace is poised to transform the entire embedded system ecosystem with a multitude of AI capabilities such as deep machine learning, image detection, and many others. This will also be transformational for existing critical business functions such as Identity management, authentication, and cybersecurity.

Multi-processor AI chipsets learn from the environment, users, and machines to uncover hidden pattern among data, predict actionable insight, and perform actions based on specific situations. AI chipsets will become an integral part of both AI software/systems as well as critical support of any data-intensive operation as they drastically improve processing for various functions as well as enhance overall computing performance.

IBM to Invest $50 Million in Research With Hospital and Medical Center and Qualcomm, Accenture and Kellogg Team to Develop VR Merchandising Solution

Stocks discussed: (NYSE:IBM) (NasdaqGS:QCOM) (NYSE:ACN) (NYSE:K)

IBM, (NYSE:IBM) through Watson Health, plans to invest $50 million in research collaborations with Brigham and Women's Hospital, a teaching hospital of Harvard Medical School, and Vanderbilt University Medical Center - to advance the science of artificial intelligence (AI) and its application to major public health issues. Work with the two institutions will concentrate on developing solutions to health issues best suited for AI. Kyu Rhee, M.D., M.P.P., vice president and chief health officer at IBM Watson Health, commented:

"Building on the MIT-IBM Watson Lab announced last year, this collaboration will include contributions from IBM Watson Health's long-standing commitment to scientific research and our belief that working together with the world's leading institutions is the fastest path to develop, advance, and understand practical solutions that solve some of the world's biggest health challenges."

"Our VR merchandising solution has the potential to transform product placement by examining consumer buying behavior in a holistic way. By combining the power of VR with eye-tracking and analytics capabilities, it allows significant new insights to be captured while consumers shop by monitoring where and how they evaluate all products across an entire shelf or aisle. Ultimately, this enables product placement decisions to be made that can positively impact total brand sales, versus only single product sales."

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, contents creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: More disclaimer info: shttps://www.investorideas.com/About/Disclaimer.asp ,

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.